-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK Receives China's National Medical Products Administration Approval For Exdensur To Treat Severe Asthma Characterised By An Eosinophilic Phenotype

Benzinga·03/30/2026 12:28:42
Listen to the news